A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis

Condition:   Symptomatic Osteoarthritis of the Knee With Kellgren-Lawrence Grade II and III Interventions:   Drug: JTA-004;   Device: Hylan G-F 20;   Other: placebo Sponsors:   Bone Therapeutics S.A;   Nordic Bioscience A/S Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials